Login / Signup

Characteristic morphological changes in anti-VEGF therapy-induced glomerular microangiopathy.

Frederick PfisterKerstin AmannChristoph DanielMonika KlewerAnke BüttnerMaike Büttner-Herold
Published in: Histopathology (2018)
aVEGF therapy-induced glomerular microangiopathy has a characteristic morphology and clinical presentation that helps to differentiate it from other causes of TMA. Awareness of these light microscopic findings allows identification of aVEGF therapy as a trigger of renal disease in critically ill cancer patients, and might therefore help in deciding on further therapy.
Keyphrases
  • stem cells
  • endothelial cells
  • bone marrow
  • cell therapy
  • replacement therapy